Our Blog

OncoSil Medical (ASX:OSL) EU commercialisation plans

24 May 2018 – OncoSil Medical Limited (ASX:OSL) Managing Director & CEO, Daniel Kenny provides an update on the company’s EU commercialsation plans, including its CE Mark Certification and Global Pancreatic Cancer programs.


Source: Finance News Network

Share this post